Giving in Europe & the Middle East
Gilead Sciences’ Giving in Europe & the Middle East grant funds nonprofit projects advancing research, care, and education in HIV, liver, blood, and inflammatory/respiratory diseases across the region.
Browse similar grants
Funder: Gilead Sciences
Due Dates: Rolling (Apply at least 6 weeks before project start date)
Funding Amounts: No explicit minimum or maximum; funding is based on project needs; grants are typically for up to one year.
Summary: Supports nonprofit-led projects advancing care, awareness, and education in HIV, liver diseases, hematology/oncology, and inflammatory/respiratory diseases across Europe & the Middle East.
Key Information: Only nonprofits in eligible countries may apply; no retroactive funding; detailed project budget required.
Description
This grant program from Gilead Sciences is designed to support projects that advance care and community engagement in Europe and the Middle East across the fields of HIV, liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), hematology and oncology, and inflammatory and respiratory diseases. The program aims to empower patient advocates, nonprofits, and healthcare professionals to improve disease awareness, prevention, professional education, and access and quality of care. Funding is intended for innovative, high-impact projects that align with Gilead’s core therapeutic areas and deliver meaningful outcomes for patients and communities.
